Duchesne GM - Search Results

1

Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques.

Duchesne GM, Haworth A, Bone E, Carter H, Ebert MA, Gagliardi F, Gibbs A, Hornby C, Martin A, Sidhom M, Wood M, Jackson M. Duchesne GM, et al. J Med Imaging Radiat Oncol. 2016 Feb;60(1):129-37. doi: 10.1111/1754-9485.12390. Epub 2015 Oct 5. J Med Imaging Radiat Oncol. 2016. PMID: 26439588

2

Radiation for prostate cancer.

Duchesne GM. Duchesne GM. Lancet Oncol. 2001 Feb;2(2):73-81. doi: 10.1016/S1470-2045(00)00223-0. Lancet Oncol. 2001. PMID: 11905798 Review.

3

Outcome, morbidity, and prognostic factors in post-prostatectomy radiotherapy: an Australian multicenter study.

Duchesne GM, Dowling C, Frydenberg M, Joseph D, Gogna NK, Neerhut G, Roberts S, Spry N, Turner S, Woo H. Duchesne GM, et al. Urology. 2003 Jan;61(1):179-83. doi: 10.1016/s0090-4295(02)02005-8. Urology. 2003. PMID: 12559292

4

Assessment of i-125 prostate implants by tumor bioeffect.

Haworth A, Ebert M, Waterhouse D, Joseph D, Duchesne G. Haworth A, et al. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1405-13. doi: 10.1016/j.ijrobp.2004.01.047. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275726

5

Prostate implant evaluation using tumour control probability--the effect of input parameters.

Haworth A, Ebert M, Waterhouse D, Joseph D, Duchesne G. Haworth A, et al. Phys Med Biol. 2004 Aug 21;49(16):3649-64. doi: 10.1088/0031-9155/49/16/012. Phys Med Biol. 2004. PMID: 15446795

6

Both pretreatment prostate-specific antigen level and posttreatment biochemical failure are independent predictors of overall survival after radiotherapy for prostate cancer.

Williams SG, Duchesne GM, Millar JL, Pratt GR. Williams SG, et al. Among authors: duchesne gm. Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1082-7. doi: 10.1016/j.ijrobp.2004.04.048. Int J Radiat Oncol Biol Phys. 2004. PMID: 15519778

7

Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer.

Skala M, Berry M, Duchesne G, Gogna K, Tai KH, Turner S, Kneebone A, Rolfo A, Haworth A. Skala M, et al. Australas Radiol. 2004 Dec;48(4):493-501. doi: 10.1111/j.1440-1673.2004.01354.x. Australas Radiol. 2004. PMID: 15601330 Review.

8

Three-dimensional conformal radiotherapy in the treatment of prostate cancer in Australia and New Zealand: Report on a survey of radiotherapy centres and the proceedings of a consensus workshop.

Tai KH, Duchesne G, Turner S, Kneebone A, See A, Gogna K, Berry M. Tai KH, et al. Australas Radiol. 2004 Dec;48(4):502-8. doi: 10.1111/j.1440-1673.2004.01355.x. Australas Radiol. 2004. PMID: 15601331

9

Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants.

Haworth A, Ebert M, St Clair S, Carey BM, Flynn A, Bottomley DM, Duchesne GM, Joseph D, Ash D. Haworth A, et al. Among authors: duchesne gm. Brachytherapy. 2005;4(2):146-53. doi: 10.1016/j.brachy.2004.12.002. Brachytherapy. 2005. PMID: 15893269

10

PSA response signatures - a powerful new prognostic indicator after radiation for prostate cancer?

Denham JW, Lamb DS, Joseph D, Matthews J, Atkinson C, Spry NA, Duchesne G, Ebert M, Steigler A, D'Este C. Denham JW, et al. Radiother Oncol. 2009 Mar;90(3):382-8. doi: 10.1016/j.radonc.2008.10.004. Epub 2008 Nov 5. Radiother Oncol. 2009. PMID: 18992951 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters